Abstract
Background Tuberculosis (TB) is a significant health issue in sub-Saharan African (SSA) countries, and artisanal mining (AM) may be a contributing factor. However, no systematic review has investigated the association between AM and TB in SSA. Therefore, this study aims to assess the burden of TB among artisanal miners in SSA.
Methods We conducted a comprehensive search of PubMed, Medline-OVID, EMBASE, and Scopus databases for studies on AM and TB published up to January 25, 2022. We presented the findings of seven studies that met our inclusion criteria narratively and through figure synthesis, and used inverse-variance weighted random-effects models to combine effect estimates for meta-analysis.
Results The overall prevalence of TB among artisanal workers was estimated to be 15% (95%CI: 8, 23), with higher rates in high TB burden countries (19%, 95%CI: 11, 28) compared to upper-moderate burden countries (8%, 95%CI: 3, 19. Further, exposure to silica dust, a common byproduct of AM, significantly increased the incidence of TB, with a pooled relative risk of 2.19 (95% CI: 1.77, 2.71). Additionally, we found that a higher number of artisanal miners in Ghana was associated with a reduction in TB incidence.
Conclusion Our findings suggest that exposure to silica dust in AM is a neglected but a significant risk factor for TB in SSA. More studies and efforts are needed to address this threat to TB control.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request
Abbreviations
- CI
- confidence interval
- OR
- odds ratio
- RR
- relative risk, rate ratio or risk ratio
- SIR
- standardized incidence ratio
- AM
- Artisanal Mining
- CXR
- chest x-ray
